INVESTORS

INVESTORS

Corporate Governance

Corporate Governance

The Board of Directors of IVERIC bio (the “Company”) sets high standards for our employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of our business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of our Company or as required by applicable laws and regulations.

Corporate Documents

In December 2019, IVERIC bio amended its Code of Business Conduct and Ethics. The amendments primarily reflect changes to better align the Code of Business Conduct and Ethics with the Company's stage of development, including, among other things, updates relating to compliance with laws, rules and regulations applicable to pharmaceutical development, interactions with healthcare providers, data privacy and international trade regulations.

Corporate Governance

Corporate Governance

The Board of Directors of IVERIC bio (the “Company”) sets high standards for our employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of our business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of our Company or as required by applicable laws and regulations.

Corporate Documents

In December 2019, IVERIC bio amended its Code of Business Conduct and Ethics. The amendments primarily reflect changes to better align the Code of Business Conduct and Ethics with the Company's stage of development, including, among other things, updates relating to compliance with laws, rules and regulations applicable to pharmaceutical development, interactions with healthcare providers, data privacy and international trade regulations.